Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis have?
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis has 2,975 citations in the OpenAlex counts ScholarIQ stores.
When was Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis published?
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis has 2018 year in the ScholarIQ index.
What is the open-access status of Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis?
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis has bronze oa status in the ScholarIQ index.
What is the DOI of Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis?
The DOI for Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis is on the source record.
What is the PMID of Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis?
The PMID for Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis is on the source record.
What is the OpenAlex record for Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis?
The OpenAlex for Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis is on the source record.